DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,196 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $9,485,000 | -15.0% | 110,575 | -16.4% | 1.60% | -21.6% |
Q2 2017 | $11,162,000 | -7.9% | 132,264 | -6.7% | 2.05% | -10.5% |
Q1 2017 | $12,123,000 | +14.3% | 141,744 | +4.0% | 2.29% | +44.1% |
Q4 2016 | $10,605,000 | +658.0% | 136,236 | +663.1% | 1.59% | +744.7% |
Q3 2016 | $1,399,000 | -22.4% | 17,852 | 0.0% | 0.19% | -29.1% |
Q2 2016 | $1,803,000 | +23.8% | 17,852 | +16.3% | 0.26% | +9.5% |
Q1 2016 | $1,456,000 | +80.4% | 15,352 | +76.7% | 0.24% | +69.2% |
Q4 2015 | $807,000 | -87.4% | 8,689 | -88.4% | 0.14% | -92.8% |
Q1 2015 | $6,387,000 | -0.9% | 75,225 | 0.0% | 1.98% | +4.8% |
Q4 2014 | $6,448,000 | – | 75,225 | – | 1.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |